Emcure Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Emcure Pharmaceuticals Ltd. on BSE

Load latest

Emcure Pharmaceuticals Ltd.

09 Jul 2025

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025

pdf

Emcure Pharmaceuticals Ltd.

04 Jul 2025

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

BSE India

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Incorporation of a Wholly-owned Subsidiary of the Company with the name "Emcure Wellness Private Limited".

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1317.00

-1.90%

SAST

Emcure Pharmaceuticals Ltd - 544210 - Closure of Trading Window

BSE India

Intimation of closure of Trading Window

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 31A Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Submission of application for seeking re-classification from the " Promoter and Promoter Group'' category to ''Public'' category

pdf

Emcure Pharmaceuticals Ltd.

25 Jun 2025

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the disclosure regarding an Order received from the Office of the Regional Director, Western Region, Ministry of Corporate Affairs, Mumbai, on June 24, 2025.

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025, 02:08PM

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Disclosure Of Key Performance Indicators (Kpis) Under The SEBI (Issue …

BSE India

Disclosure of Key Performance Indicators (KPIs) under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025, 02:01PM

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)

BSE India

Please find enclosed herewith a Press Release titled "Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary, Zuventus Healthcare Ltd."

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025, 01:56PM

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Intimation Under Regulation 31A Of The SEBI (Listing Obligations And …

BSE India

Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Outcome of the meeting of the Board of Directors considering requests for re-classification from the "Promoter and Promoter Group'' category to ''Public'' category

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025, 12:28PM

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Intimation of proposed incorporation of a Wholly-owned subsidiary by the name "Emcure Wellness Private Limited"

pdf

Emcure Pharmaceuticals Ltd.

21 Jun 2025, 12:02PM

1317.00

-1.90%

Company Update

Emcure Pharmaceuticals Ltd - 544210 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Acquisition of Equity Shares, constituting 20.42% of the total issued and paid-up capital of Zuventus Healthcare Limited, a subsidiary of the Company, thereby making Zuventus a wholly-owned subsidiary of the Company.

pdf